InvestorsPrism
  • Home
  • Indexes
    • All Indexes
    • Cannabis
    • EV
    • Gene Therapy
    • MedDevices
    • MedDiagnostics
    • Solar
    • Uranium
    • Vaccines & Cell Therapy
    • Web 3.0
  • Companies
  • Trending News
    • Latest
    • Markets
    • Finance
    • Economy
    • Technology
    • Earnings
    • Healthcare
    • Prism Daily
  • Equity Research
    • Login
    • Register
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Cannabis
    • EV
    • Gene Therapy
    • MedDevices
    • MedDiagnostics
    • Solar
    • Uranium
    • Vaccines & Cell Therapy
    • Web 3.0
  • Companies
  • Trending News
    • Latest
    • Markets
    • Finance
    • Economy
    • Technology
    • Earnings
    • Healthcare
    • Prism Daily
  • Equity Research
    • Login
    • Register
    • User Profile
    • Log Out

Home Biotech

Category: Biotech

March 22 at 2:54 pm

Connect Biopharma: Phase 2b Data Shows Rapid and Sustained Improvement in Atopic Dermatitis

Global clinical-stage biopharmaceutical company, Connect Biopharma (Nasdaq: CNTB), has announced that post hocdata analysis from its Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis… [Read More]
March 21 at 9:31 am

InMed Demonstrates Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions

Leading cannabinoid researcher, developer and manufacturer, InMed Pharmaceuticals (Nasdaq: INM) has demonstrated the anti-inflammatory potential of rare cannabinoids in skin conditions. The company has sponsored… [Read More]
March 16 at 1:53 pm

Aridis Meets Primary and Secondary Endpoints in Cystic Fibrosis Clinical Trial

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) has met the primary and secondary endpoints in safety and pharmacokinetics in a Phase 2a clinical trial evaluating a treatment… [Read More]
March 15 at 4:01 pm

ThermoGenesis Announces California Facility with Potential for $10-16M Annual Revenue

ThermoGenesis Announces California Facility with Potential for $10-16M Annual Revenue ThermoGenesis Holdings (Nasdaq: THMO) will roll out a new California facility containing 12, class-7, ReadyStart… [Read More]
March 08 at 9:01 am

Protagonist Therapeutics Delivers Positive Topline Results in Psoriasis Study

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) has received positive topline results in its Phase 2b FRONTIER 1 clinical trial evaluating a treatment for psoriasis. The study… [Read More]
March 07 at 9:35 am

Unicycive Successfully Raises $130M To Launch Renazorb For Dialysis Patients

Unicycive Therapeutics, Inc., (Nasdaq: UNCY) has raised up to $130M to support its New Drug Application (NDA) submission with the FDA for approval and potential… [Read More]
March 06 at 1:47 pm

BridgeBio Reports Positive Phase 2 Results; Begins Enrolling Patients in Phase 3 Study

Commercial-stage biopharmaceutical company, BridgeBio (Nasdaq: BBIO), has announced positive results from its PROPEL2 Phase 2 clinical trial demonstrating potential best-in-class efficacy and a clean safety… [Read More]
March 03 at 3:34 pm

Lexaria’s Diabetes Study Results Feature Weight Loss and Improved Triglyceride and Cholesterol Levels

Lexaria Bioscience (NASDAQ: LEXX) shared the notable results of its recent diabetes animal model study, with positive outcomes including weight loss and improved triglyceride and… [Read More]
March 03 at 2:05 pm

Incannex Inks Manufacturing Agreement for Psilocybin Drug Product

Incannex Healthcare Limited (Nasdaq: IXHL), a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs, has engaged a manufacturer… [Read More]
March 03 at 12:34 pm

Soligenix Virus Candidate More Critical Than Ever with Marburg Virus Outbreak in Africa

Authorities in Equatorial Guinea are working to contain an outbreak of Marburg virus that began in February 2023 and has resulted in 11 deaths and… [Read More]
March 02 at 3:44 pm

Lipella Creates Oral Health Scientific Advisory Board

Lipella Pharmaceuticals (Nasdaq: LIPO), has appointed a five-member Scientific Advisory Board in oral health to focus on the development of LP-310 for the treatment of… [Read More]
March 01 at 9:11 am

Orchard Therapeutics Secures Swedish Reimbursement Agreement for Libmeldy

Global gene therapy company, Orchard Therapeutics (Nasdaq: ORTX) has reached an agreement that will allow reimbursed access to Libmeldy for eligible metachromatic leukodystrophy (MLD) patients… [Read More]

Posts navigation

Page 1 Page 2 Next page
InvestorsPrism

Copyright © 2023 Investors Prism
All rights reserved

Company

  • About Us
  • Contact Us
  • Privacy Policy
  • Disclaimer

News

  • Latest
  • Markets
  • Finance
  • Economy
  • Technology
  • Earnings
  • Healthcare
  • Prism Daily

Indexes

  • Cannabis
  • EV
  • Gene Therapy
  • MedDevices
  • MedDiagnostics
  • Solar
  • Uranium
  • Vaccines & Cell Therapy
  • Web 3.0